SIXTH ELEMENT CAPITAL
Sixth Element Capital is currently managing its first fund: the £70m CRT Pioneer Fund (CPF) to create the future of cancer therapy and diagnosis.
SIXTH ELEMENT CAPITAL
Industry:
Health Care Health Diagnostics
Status:
Active
Contact:
+44 (0)7774 269552
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-09 | NeoPhore | Sixth Element Capital investment in Series B - NeoPhore | 15.2 M GBP |
| 2019-11-21 | Azeria Therapeutics | Sixth Element Capital investment in Series B - Azeria Therapeutics | 32 M GBP |
| 2018-09-04 | Azeria Therapeutics | Sixth Element Capital investment in Series A - Azeria Therapeutics | 4 M GBP |
| 2018-06-21 | AdoRx Therapeutics | Sixth Element Capital investment in Series A - AdoRx Therapeutics | 10 M USD |
| 2017-11-16 | NeoPhore | Sixth Element Capital investment in Venture Round - NeoPhore | 3 M GBP |
| 2017-01-09 | Macrophage Pharma | Sixth Element Capital investment in Series A - Macrophage Pharma | 9 M GBP |
| 2016-09-28 | Achilles Therapeutics | Sixth Element Capital investment in Seed Round - Achilles Therapeutics | 13.2 M GBP |